These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12384555)

  • 21. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.
    Mizuiri H; Yoshida K; Toge T; Oue N; Aung PP; Noguchi T; Yasui W
    Cancer Sci; 2005 Sep; 96(9):571-7. PubMed ID: 16128742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer.
    Cvetković D; Williams SJ; Hamilton TC
    Clin Cancer Res; 2003 Mar; 9(3):1013-20. PubMed ID: 12631600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
    Sirchia SM; Ren M; Pili R; Sironi E; Somenzi G; Ghidoni R; Toma S; Nicolò G; Sacchi N
    Cancer Res; 2002 May; 62(9):2455-61. PubMed ID: 11980632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
    Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
    Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between expression of cellular retinol-binding protein 1 and its methylation status in larynx cancer.
    Peralta R; Valdivia A; Alvarado-Cabrero I; Gallegos F; Apresa T; Hernández D; Mendoza M; Romero P; Paniagua L; Ibáñez M; Cabrera L; Salcedo M
    J Clin Pathol; 2012 Jan; 65(1):46-50. PubMed ID: 22049223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
    Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.
    Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P
    Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
    Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
    Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
    Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
    Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG hypermethylation of cellular retinol-binding protein 1 contributes to cell proliferation and migration in bladder cancer.
    Toki K; Enokida H; Kawakami K; Chiyomaru T; Tatarano S; Yoshino H; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Int J Oncol; 2010 Dec; 37(6):1379-88. PubMed ID: 21042705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of the MGMT gene in cancer.
    Soejima H; Zhao W; Mukai T
    Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
    Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
    Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.
    Tessema M; Willink R; Do K; Yu YY; Yu W; Machida EO; Brock M; Van Neste L; Stidley CA; Baylin SB; Belinsky SA
    Cancer Res; 2008 Mar; 68(6):1707-14. PubMed ID: 18339850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.